
Is it reasonable to administer pegfilgrastim on day 1 of a myelosuppressive chemotherapy regimen? A cost-utility analysis
Billingsley, Caroline C., Cohn, David E., Crim, Aleia K., Li, Quan, O’Malley, David M., Havrilesky, Laura J.Volume:
14
Année:
2018
Langue:
english
Journal:
Cancer Treatment and Research Communications
DOI:
10.1016/j.ctarc.2017.11.003
Fichier:
PDF, 179 KB
english, 2018